Home/Pipeline/Nanobody‑based theranostic platform

Nanobody‑based theranostic platform

Cancer imaging and therapy

PreclinicalActive

Key Facts

Indication

Cancer imaging and therapy

Phase

Preclinical

Status

Active

Company

About Cyclotek

Australian PET radiopharma supplier with a national cyclotron network and proprietary tracer portfolio.

View full company profile

Therapeutic Areas

Oncology Neurology Cardiology